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K. L. HOLLOWAY*, K. STAUB†, F. RU¨HLI† and M. HENNEBERG*
*Biological Anthropology and Comparative Anatomy Research Unit, University of
Adelaide, Australia and †Centre for Evolutionary Medicine, Institute of Anatomy,
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Summary. This study investigated the trends in tuberculosis mortality through
time in Switzerland. Information on the decline in mortality before chemo-
therapies were introduced may be useful in developing countries where drug-
resistant tuberculosis is now becoming a major problem. Swiss data were
collected from historical records and comparative data were obtained from
the literature for England and Wales, New York, Japan, Brazil and Sierra
Leone. Logistic curves were ﬁtted to examine the rate of decline before intro-
duction of pharmacotherapies and these show that the decline would have
continued without the introduction of chemical therapies, including antibiotics.
In Switzerland, England and Wales and New York, the decline had occurred
long before the introduction of speciﬁc anti-tuberculosis agents. In Brazil and
Japan, chemical therapy was co-incident with the decline in tuberculosis mor-
tality rates. Overall, it is suggested that the effective control of tuberculosis
can be achieved through a combination of chemical interventions, conservative
therapy (rest, good nutrition, ventilation, etc.) as well as public health interven-
tions addressing hygiene, nutrition, reducing exposure to infections and educat-
ing the population about tuberculosis.
Introduction
Deﬁnition of a disease as a balance between infection and immunity
There are a multitude of deﬁnitions of a ‘disease’ because, like with most common
words, the usage is varied. It is nearly impossible to reach an agreement on one formal
deﬁnition of a disease. The most general statement would be that disease is a detrimental
deviation from the structural or functional norm (anatomical, physiological or psycho-
logical norm in the case of living organisms). What a ‘norm’ is remains equally debat-
able. One of the most common categories of diseases are infectious diseases. In the
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classic Koch deﬁnition, these are diseases caused by a parasitic organism, usually a
small one like a bacterium or a virus, which enters a body and alters its normal func-
tions (Kaufmann, 2003). The human body is a microcosm of ﬂora and fauna kept in
balance by the interactions of the vertebrate organism and its multitude of microorgan-
ismic inhabitants. The immune system plays a decisive role in controlling how those
inhabitants interact with the host organism. Tuberculosis is a good example of the inter-
action of infestation by a particular category of bacteria, Mycobacterium, and immunity.
Most humans are infected by Mycobacteriae but do not develop any pathological signs
or symptoms (Cole et al., 2005). Some humans, with lower immunity, will suffer the
consequences of uncontrolled expansion of mycobacterial ﬂora, which produces a disease
invading various tissues of the body and, if immunity does not improve or if the parasite
growth is not artiﬁcially checked by chemotherapy, may die (Roberts & Buikstra, 2003;
Cole et al., 2005).
Killing germs versus improving immunity: what can eradicate tuberculosis?
Tuberculosis (TB) is an ancient disease that caused the deaths of approximately
25% of the European adult population during the 1700s and early 1800s (Stead, 2001).
At present, the World Health Organization estimates that approximately one-third of
the world’s population are infected with the causative organism, Mycobacterium tuber-
culosis (World Health Organization, 2012). However, only approximately 10% of all
individuals infected, most commonly those with lowered immunity, will ever develop
active disease (Wilbur et al., 2008). Signs and symptoms of TB are usually associated
with the respiratory system and include coughing, difﬁculty breathing, bloody sputum,
weakness, lethargy, loss of appetite and weight, night sweats, pallor and chest pain.
Transmission of the bacterium occurs through the generation of aerosolized droplets
containing bacteria, usually through excessive coughing.
Antibiotics and other chemical therapies were introduced in the 1940s and 1950s,
which allowed the ‘cure’ of TB by killing the pathogenic organism in the patient’s
body. However, their use caused the development of drug-resistant bacteria through
the process of natural selection (Herzog, 1998). Some strains of the TB bacillus have
been found to be multiple-drug resistant (MDR), meaning they are resistant to the
two ﬁrst-line chemical agents (isoniazid and rifampin) (Wang et al., 2008). Some
strains have even been observed to be extensively drug resistant (XDR) and are very
difﬁcult and expensive to treat (estimated cost US$500,000–1,000,000 per patient for
hospital-based care in high-income countries) (Michael, 2013). In Peru, the incidence
of TB has declined 3.7% per year since 1996, but the incidence of cases with MDR
strains has increased by 4.5% (Manjourides et al., 2012). These data show that the pro-
portion of MDR-TB cases is increasing. In Belarus, a study by Skrahina et al. (2012)
has shown that 35.3% of newly diagnosed TB patients and 76.5% of previously treated
patients had MDR-TB. Overall, this gave an average of approximately 50% of TB
cases being of the MDR type.
Before chemical therapies including antibiotics appeared, the typical treatment for
TB involved increasing a patient’s immunity through improved nutrition, hygiene and
rest (conservative therapies) (Kaplan, 1959). All of these measures were used at sanatoria
(Rucker & Kearny, 1913) and helped to cause and maintain a decline in mortality due
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to TB throughout the 19th century, long before antibiotics were introduced. The main
factors in this decline are important because they can help to devise new treatment
methods for patients with MDR or XDR, which are difﬁcult to treat with antibiotics
alone.
The historical trend of TB mortality decline
Several authors (McKeown, 1976; Szreter, 1988; Fairchild & Oppenheimer, 1998)
have reported and investigated the decline in mortality due to TB over time. These
studies mainly used data from England and Wales during the 19th and early 20th
centuries in order to make interpretations about the reasons why TB mortality declined
over time.
In his book, McKeown describes the growth in population size throughout history,
attributing the increase to a reduction in mortality, rather than an improvement in
fertility. He then goes on to describe the possible causes of the mortality decline, focus-
ing on the major causes of death during the 19th century, i.e. infectious diseases. He
mainly describes airborne infectious diseases because they were a large part of the
decline. Several factors were considered, including a decrease in virulence of micro-
organisms, medical interventions (immunization and therapy), levels of exposure and
nutrition. All of these factors were considered in turn, with the ﬁnal conclusion that
nutrition was the main reason for the decline in mortality (due to infectious airborne
diseases). For TB, the authors suggested the reason for the mortality decline was a
reduction in exposure because the disease was less prevalent, brought about by an im-
provement in nutrition. The work done by Grifﬁths et al. (2002) was also highlighted,
giving reasons why the interpretation of medical interventions as the main reason for
mortality decline is incorrect.
A later investigation in the same area was conducted by Szreter (1988). The author
appraised the earlier work by McKeown and highlighted various problems. He stated
that the interpretation was done by elimination and that the nutrition hypothesis was
not as carefully investigated as the other factors were. Nutrition also did not account
for decline of some diseases such as smallpox, which declined for other reasons (in this
case, immunization). Additionally, food and waterborne diseases were a substantial
part of the mortality decline. These were signiﬁcantly affected by hygiene and living
conditions and less affected by nutritional status. McKeown also grouped ‘public
health’ as a broad factor and did not consider many of the smaller parts. The work
also treated all airborne diseases together, but mortality trends for separate groups
were different. Overall, Szreter suggested that only TB would really support the nutri-
tion hypothesis proposed by McKeown. However, despite this, there are certainly other
factors affecting the decline of TB including addressing overcrowding, lack of sunlight,
ventilation and occupational hazards (dust/smoke) through public health interventions.
Additionally, urban and rural populations had a different exposure to, and risk of, TB.
Szreter instead suggested a different reason for the mortality decline, associated with
public health. The author listed the number of Public Health Acts introduced in Britain
addressing a variety of factors including hygiene, living conditions, ventilation and food
quality. He also noted that McKeown’s theory about a larger quantity of food resulting
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in better nutrition may not be true if food quality is poor. In fact, it may spread disease
faster than if a smaller amount of food was available.
Another later study (Fairchild, 1998) reviewed both McKeown’s and Szreter’s
work, highlighting that although each had their own interpretations, neither had sufﬁ-
cient evidence to support their conclusions. There is a need for multifactorial models
that include housing, ventilation, hygiene, working conditions, nutrition and other
infections, but it is impossible to test for each one of these while keeping the others
constant. The author continues with a description of sanatoria and how segregation
and consequent lowering of transmission of the disease has been the only consistently
effective measure for controlling TB. The authors ﬁnally concluded that ‘social medi-
cine’ was responsible for the decline in TB and this included public health, awareness,
environmental conditions, housing, food and working hours. Overall, these previous
works show the difﬁculty in determining the exact reasons for the decline in TB
mortality over time. It is likely that a combination of factors related to public health,
nutrition, segregation of the infected and hygiene were responsible for the decline in
mortality.
Since the precise reasons for the decline in TB are difﬁcult to determine, this study
investigated the decline in countries other than England and Wales in order to obtain a
more detailed view of the events occurring. These data were then compared with those
of England and Wales against the historical background of speciﬁc actions taken in
relation to sanitation and disease control.
Methods
Information about tuberculosis mortality was collected from numerous sources. Infor-
mation was collected for Canton Zu¨rich from both the Stadtarchiv (‘city-archive’; Stadt
Zu¨rich, 2012) and Staatsarchiv (‘canton-archive’; Canton of Zu¨rich, 2012) in the city of
Zu¨rich, Switzerland. The Stadtarchiv held records for causes of death in Zu¨rich city
from 1893 to 1933, which included mortality attributed to tuberculosis. There were
many records in this archive, but the following were focused on: Tuberkulose (Tubercu-
losis): two volumes; 1912–1932 and 1932–1935; Tuberkulose Sterbefaelle (Tuberculosis
mortality): ﬁve volumes; 1903–1905, 1905–1915, 1915–1920, 1920–1934 and 1929–
1936. Data were also collected from a volume of primary historical statistics for
Switzerland (State Statistics) entitled Historische Statistik der Schweiz (Ritzmann-
Blickenstorfer, 1996). Data for the entire country (Switzerland) were also collected
from these sources as well as from the World Health Organization for the years 1867
to 2005.
Much of the information was obtained from previously published literature regard-
ing England and Wales (Blower et al., 1995), New York (United States) (Drolet &
Lowell, 1952), Japan (Johnston, 1995), Brazil (Antunes & Waldman, 1999) and Sierra
Leone (World Health Organization, 2012). Data from publications regarding mortality
for TB in England and Wales, as well as New York (United States), were collected and
entered into Microsoft Excel for direct comparison with the Swiss data collected in this
study (from Canton Zu¨rich as well as the whole of Switzerland). England and Wales
and New York (United States) were considered similar in terms of TB mortality trends
(all Westernized, similar history regarding anti-TB health measures). Data from Japan,
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Brazil and Sierra Leone were collected for comparison as these countries had a different
history of TB prevention and control (as well as lacking Westernization for many years).
Important historical dates for events in the prevention and control of TB were
added for further interpretation of the mortality data. These events included (among
others) the introduction of Public Health and Sanitation Acts, compulsory reporting
of TB cases and the introduction of streptomycin.
The logistic curve was chosen as the basic description of change in the relationship
between disease prevalence and population characteristics. This curve describes the
alteration of an occurrence of a particular feature in a population after the introduc-
tion of a change in the relationship of this feature to the population. The curve has
a characteristic shape resulting from the fact that a change initially has small effects,
then its effects increase as the change spreads and when it exhausts the prevalence of
a feature, it comes to an asymptotic end. Logistic models were ﬁtted to the data for
Switzerland (whole country), England and Wales and New York in the form:
M ¼ f0 þ fz  f0
1þ 10ðtcÞðwÞ
where M is the mortality rate observed at a given year (t); t is the year; f0 is the lower
asymptote (the lowest mortality rate observed); fz is the upper asymptote (highest mor-
tality rate observed); c is the inﬂection point, where the rate of decline in mortality is
the highest; and w is the rate of decline at the inﬂection point (i.e. the highest rate).
The values of the parameters f0, fz, w and c were initially estimated by observing
the scatter of datum points against time and the best ﬁt was obtained by their iterative
alterations (bootstrapping) using the least squares method. The year (t) and mortality
(M ) were the independent and dependent variables, respectively, and thus did not need
estimating.
These models were extrapolated to show the expected trend in TB mortality without
the introduction of antibiotics in order to investigate the efﬁciency of conservative
therapies (rest, good nutrition, ventilation, etc.) as well as public health improvements
(addressing hygiene, nutrition and reducing exposure to infections as well as educating
the population about TB) on the disease.
Results
Historical events in the decline of tuberculosis
The City of Zu¨rich and Canton Zu¨rich (Switzerland). The TB mortality rate for
Canton Zu¨rich (Switzerland) was above 350 per 100,000 during the 1840s (Fig. 1).
The mortality rate declined from that time onwards, reaching 224 by 1869. The lack
of information for the early 1870s is probably due to the Prussian–French War during
1870 and 1871. Although Switzerland did not participate in this war, it took in a large
number of refugees and the instability at the time would have affected external and
international actions such as trade. From 1878 to 1888, the TB mortality rate increased
slightly from 210 to 224 per 100,000. There was a major economic crisis period in the
1880s and many people emigrated from Switzerland (Schoch et al., 2011). From 1893,
the TB mortality rate dropped steadily until the end of the data shown here (1933).
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This decline was associated with the development of X-rays for diagnosis (1895),
the opening of the ﬁrst sanatorium (in Davos, 1896), the introduction of the BCG
vaccine (1921) and ﬁnally compulsory TB reporting and treatment introduced in 1928
(Gesetzgebung: Zu¨rich, 1928).
For the city of Zu¨rich, the records start only from 1893. This is easily explained
because in 1893 the city expanded substantially in terms of area and population
(Steinberg, 1996). Thus the statistics collected are for a completely differently deﬁned
‘City of Zu¨rich’ than in years preceding 1893. The initial TB mortality rate was higher
in the city than in the entire canton. In fact, the rate in the city for 1893 was 180 per
100,000, higher than in the canton for this same year. Despite the initial rate being
higher, the decline in mortality in the city was faster than in the canton. From 1893 to
1933, the mortality rate declined from 401 to 138 per 100,000. There was a reversal
from the decline in 1918 when the Spanish ﬂu (inﬂuenza) epidemic caused a brief
increase in mortality from TB.
England and Wales. In England and Wales, similar to Switzerland, TB mortality
rates exceeded 350 per 100,000 prior to the 1840s (Fig. 2). By 1846, the rate had fallen
to around 300 per 100,000. Mortality continued to decline steadily, reaching about 50
per 100,000 in the 1940s, prior to the introduction of pharmacotherapies. Since then it
declined further until approximately 1960, when it had reached 5 per 100,000. After
Fig. 1. Tuberculosis mortality rate per 100,000 population for Canton Zu¨rich (diamonds)
and the City of Zu¨rich (line) in Switzerland. Data for Canton Zu¨rich cover 1840 to 1943.
The City of Zu¨rich data cover 1893 to 1933. Historical dates associated with tuberculosis
prevention and control are included.
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this, the mortality rate was close to zero and could not decline much further. During
the period of steady decline, a large number of events aimed at the control and pre-
vention of TB occurred. A number of these events included the introduction of laws
including the ‘Poor Law’, Sanitary and Public Health Acts (1846, 1848, 1866 and
1870s), the Housing Act (1890) and a Public Health Act speciﬁc for TB (1921) (Szreter,
1988; Wilson, 2005). These Acts helped to prevent the spread of disease between
groups in the population with different levels of risk for TB, and addressed hygiene,
living conditions, exposure risk (for bovine TB) and nutrition. In 1836, the registration
of death became compulsory and this resulted in an improvement in reporting of
causes of death (Szreter, 1988). A notiﬁcation of Infectious Diseases Act was estab-
lished in 1889, requiring the reporting of all cases of infectious diseases. This allowed
many of the previously unknown cases of TB to be located and dealt with more appro-
priately. Surgical interventions for TB were introduced in 1910, when the ﬁrst pneumo-
thorax (lung collapse) operation was performed. Compulsory reporting of TB did not
come into effect until 1913 and as such, before this, many cases may have gone unre-
ported. The ﬁnal step in the control of TB in England and Wales was the introduction
of the speciﬁc anti-TB antibiotic, streptomycin. After this time, mortality from the
disease had declined substantially and the disease was no longer a major cause of death
among the population.
Fig. 2. Tuberculosis mortality rate per 100,000 population for England and Wales
between 1838 and 2006. Historical dates associated with tuberculosis prevention and
control are included.
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New York (United States of America). The TB mortality rate in New York was
above 350 per 100,000 until about 1887 and did not drop below 300 until after 1890
(Fig. 3). During the years 1918 to 1924, the mortality rate due to TB declined from
around 200 to 100 per 100,000. After this time, the mortality rate declined slower at a
relatively constant rate until 1950 when pharmacotherapies became established.
As in England and Wales, a number of laws were introduced to help control TB.
One of these included an improved reporting of cases, free examination of sputum
and home visits for consumptives (1894) (Drolet & Lowell, 1952). Other modiﬁcations
to public health were made early in the 20th century, including separating TB from
the rest of the population (1901), the Housing Law (1901), home visits by nurses
(1939), X-rays for school teachers (1942) and government-funded treatment (1947).
Compulsory reporting of TB was introduced in 1897. The anti-TB drug streptomycin
was introduced in 1947. This allowed effective treatment of TB but did not signiﬁcantly
impact the rate of mortality decline. The last measure to be implemented was the BCG
vaccine in 1949. By this time, the mortality due to TB was low and this ﬁnal measure
had little impact on the rate.
Japan. In contrast to Switzerland, England & Wales and New York, the mortality
rate in Japan was below 100 per 100,000 between 1886 and 1888 (Fig. 4). The rate
increased steadily until 1910, when it was 231 per 100,000. The mortality rate ﬂuctuated
between 1911 and 1918, but was increasing overall. This increase in mortality rate
Fig. 3. Tuberculosis mortality rate per 100,000 population for New York (United
States) between 1880 and 1950. Historical dates associated with tuberculosis prevention
and control are included.
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occurred during the initial heavy industrialization of the country (Johnston, 1995).
Tuberculosis mortality would have increased partly as a result of poor living conditions
in ‘on site’ accommodation for factory workers. In 1918, workers were allowed to
commute to their workplace rather than living on site and this gradually resulted in a
decrease in mortality due to TB (Johnston, 1995). In 1918, the mortality rate was 251
and this decreased to 194 per 100,000 by 1924. In 1926, a Factory Law was introduced,
protecting workers as well as women and children in the workplace. However, from
1933, the recorded mortality rate began to increase. This was due to a combination of
compulsory reporting of cases introduced in 1931 as well as the Great Depression and
the effects of war on the economy. It is worth noting, however, that mortality rates
during the early 20th century remained well below 300 per 100,000, roughly comparable
to what these rates were at the same period in Europe and New York. Towards the end
of World War II, TB had become a major problem and some further measures were
introduced to help combat the disease. In 1941, reporting and treatment of TB were
made compulsory in young males. The BCG vaccine was introduced in 1943. After
World War II, cases of TB were reported more accurately and medicine was able to
help fully control the disease. From 1946 to 1985, the mortality rate decreased from
185 to 4.5 per 100,000. Most of this decline was associated with the introduction of
streptomycin in 1948, followed by the other anti-TB drugs, para-aminosalicylic acid
and isoniazid, in the early 1950s. Japan is different in that the pattern of mortality does
not begin at a high level. Mortality increased and was then controlled by public health
Fig. 4. Tuberculosis mortality rate per 100,000 population for Japan between 1886 and
2006. Historical dates associated with tuberculosis prevention and control are included.
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measures, before medication ﬁnally reduced the disease to a level where it was no longer
a major cause of death. Mortality rates also never reached the same level as in Switzer-
land, England and Wales and New York. It is difﬁcult to say to what extent the post-
1950 decline of mortality was impacted by non-pharmacological measures.
Brazil and Sierra Leone. In these two countries, public health interventions occurred
very late in comparison with Switzerland, England and Wales and the United States.
Thus they serve as a useful comparison showing that anti-TB drug therapy is indeed effec-
tive at controlling TB mortality (Fig. 5).
In Brazil, at the end of the 19th century the mortality rate was just below 200 per
100,000, a moderately high rate compared with Europe and New York in the same
period. The decline since then was slow and unsteady, but brought the mortality to
less than 100 per 100,000 population by the mid-1940s, just prior to the introduction
of pharmacotherapies. When medication was introduced, the mortality rate declined
substantially at a rapid rate until it reached a level low enough to eliminate TB as
a major cause of mortality in Brazil (Antunes & Waldman, 1999). As in the case of
Japan, it is impossible to separate effects of non-pharmacological measures.
In Sierra Leone, there are data for only 1990 to 2010, but it is clear that the TB
mortality rate was, and still is, increasing at an alarming rate. In this African country,
TB control is complicated by poor public health, lack of hygiene, HIV and probably
increasing number of drug-resistant TB strains. In this case, although chemical therapies
are available, they are ineffective. A strategy to reverse this trend can be developed but
it must take into account a number of approaches.
Fig. 5. Tuberculosis mortality rate per 100,000 population for Brazil (1900 to 1990)
and Sierra Leone (1990 to 2010).
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Logistic ﬁtting
Logistic curves were ﬁtted to the data for Switzerland (whole country), England
and Wales and the United States. Two (and in one case, three) separate equations
were required to fully describe the data. Time periods best ﬁtted by separate curves
may have corresponded to a speciﬁc event during the decline of TB: the introduction
of medication. Streptomycin implementation was observed to cause an increase in the
rate (w) of decline compared with earlier time periods. In many countries during the
ﬁrst few years of streptomycin use the datum points show a signiﬁcant decrease and it
was very difﬁcult to include these data when estimating parameters of a single curve, so
they were excluded from the estimations.
Switzerland. The mortality rate for Switzerland is shown in Fig. 6. The data for
Canton Zu¨rich or Zu¨rich city were not modelled because the date range ended before
the introduction of antibiotics and this method was intended to compare the rate of
decline before and after the introduction of these therapies. The two time periods ﬁtted
with separate logistic curves were: (i) 1867 to 1941 and (ii) 1946 to 2005. The equations
that best ﬁt the data for these two time periods are:
(i) M ¼ 305
1þ 10ðt1925Þð10:034Þ and
(ii) M ¼ 450
1þ 10ðt1927Þð10:042Þ
Fig. 6. Tuberculosis mortality rate per 100,000 population for Switzerland for 1867 to
2005. A logistic curve with R2 ¼ 0.993 has been ﬁtted to the data. The logistic ﬁt has
been extrapolated. The inset shows a closer view of the time when streptomycin was
ﬁrst introduced. Symbols correspond to the real data, the solid line is the logistic ﬁt
and the dashed line is an extrapolation of the logistic ﬁt using only the ﬁrst equation
(pre-pharmacotherapy).
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The R2 value for this double-logistic ﬁt was 0.993. From the logistic models, the
rate of decline can be observed to increase after 1946, when antibiotics were introduced.
However, this is only a 24% increase in rate indicating that TB was well controlled before
the implementation of antibiotics. The inﬂection point (c; where the rate of decline is
highest) does not differ much between the two separate models as if they were parts of
the same process. This could indicate, again, that antibiotics did not have a signiﬁcant
impact on TB mortality in Switzerland, but rather supported the decline already occurring.
England and Wales. For England and Wales, ﬁtting of data required three separate
models: (i) 1838 to 1878, (ii) 1883 to 1937 and (iii) 1941 to 2006 (Fig. 7). This indicates
there were three time periods where different factors were active in reducing the
mortality from TB. The equations for these three different time periods are:
(i) M ¼ 250
1þ 10ðt1840Þð10:050Þ
(ii) M ¼ 405
1þ 10ðt1880Þð10:020Þ
(iii) M ¼ 450
1þ 10ðt1929Þð10:055Þ
Fig. 7. Tuberculosis mortality rate per 100,000 living for England and Wales for 1878
to 1950. A set of three logistic curves with R2 ¼ 0.995 has been ﬁtted to the data. The
logistic ﬁt has been extrapolated. Symbols correspond to the real data, the solid line is
the logistic ﬁt and the dashed line is an extrapolation of the logistic ﬁt using the second
logistic curve (pre-pharmacotherapy).
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These three models were combined in order to fully explain the data and the R2
value for this ﬁt is 0.995. When comparing the three different equations, corresponding
to different time periods, the rates (w) begin at 0.050, decrease to 0.020 and then in-
crease again to 0.055. Thus it can be observed that the initial decline of TB during
time period (i) (1838 to 1878) was relatively fast, nearly as fast at following the intro-
duction of antibiotics. After 1878, up to 1941, the decline slowed, but still a decrease in
mortality occurred. During the ﬁnal time period (1941 to 2006) the decline increased in
rate again, to slightly more than it was in the ﬁrst time period. It is likely that the initial
decline was due to the factors addressed by public health interventions (nutrition,
hygiene, living conditions, etc.), while the ﬁnal decline was inﬂuenced by antibiotics.
The inﬂection point (c, date at the highest rate of decline) increases through the three
different time periods: from 1840 to 1880 to 1929 in time periods (i), (ii) and (iii), re-
spectively. The different values of c indicate that three separate processes are occurring.
The United States of America (New York). For New York, ﬁtting required distin-
guishing two periods with separate logistic models (Fig. 8). These two time periods
were: (i) 1878 to 1917 and (ii) 1921 to 1948. The time span corresponding to the third
period in England and Wales (1940s to 2006) was not studied. The equations ﬁtted to
these data were:
(i) M ¼ 230
1þ 10ðt1892Þð10:050Þ and
(ii) M ¼ 297
1þ 10ðt1904Þð10:025Þ
Fig. 8. Tuberculosis mortality rate per 100,000 living for New York (United States) for
1878 to 1950. A logistic curve with R2 ¼ 0.971 has been ﬁtted to the data. The logistic ﬁt
to pre-pharmacotherapy data has been extrapolated. Symbols correspond to the real data,
the solid line is the logistic ﬁt and the dashed line is an extrapolation of the logistic ﬁt.
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These two equations gave a combined R2 value of 0.971, indicating a reasonably
good ﬁt, but some data were not well represented by the model. This discrepancy is
probably due to changes in the reporting system, where some cases of TB went unre-
ported and, after a certain year, compulsory reporting of TB cases was introduced. An
attempt was made to solve this issue by artiﬁcially increasing the mortality rate values
before 1898 (Fig. 9). A logistic model was ﬁtted to the modiﬁed data, with equation:
(iii) M ¼ 370
1þ 10ðt1892Þð10:052Þ
The other data (after 1920) retained the same equation as before ((ii) above).
Comparing equations (i) and (ii) it can be observed that the rate (w) decreases by
half between the earlier and later time periods (0.05 to 0.025), indicating that the rate
of decline was faster during the time period 1878 to 1917 than during 1921 to 1948.
This is interesting because the latter time period included, at its very end, the introduc-
tion of antibiotics. This indicates that antibiotics had little impact on the already rapid
and largely completed decline of TB mortality. The same decrease is observed when
comparing (i) and (iii) (modiﬁed data). The equations (i) and (iii) also have the same
value for c (inﬂection point, where the decline is most rapid). However, between the
two time periods, the value of c is different. In the earlier time period, the rate of
decline is highest at 1892 and in the later time period during 1904. This difference in
Fig. 9. Tuberculosis mortality rate per 100,000 living for New York (United States)
for 1878 to 1950. The data for 1878 to 1897 have been modiﬁed from Fig. 8 due to
under-reporting before the introduction of compulsory recording of TB cases in 1898.
A logistic curve with an R2 value of 0.996 has been ﬁtted to the data.
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the value of c indicates that at least two separate processes are affecting the decline of
TB during the entire time period reported (1878 to 1897). There were only a few differ-
ences between the modiﬁed and unmodiﬁed data for New York. The rate is slightly
higher in the modiﬁed data and the upper asymptote (highest mortality rate) was
higher for the modiﬁed data compared with the unmodiﬁed data. This is expected,
since the modiﬁcation was to artiﬁcially increase values to account for the under-
reporting of TB cases before 1898.
Extrapolation of logistic models
The models ﬁtted to the data for Switzerland, England and Wales and the United
States (New York) were extrapolated to show the expected trend of TB mortality if
antibiotics had not been introduced. For Switzerland, this was achieved by extrapolat-
ing equation (i) to the year 2040. For England and Wales, equation (ii) was used to
model the years from 1941 to 2040 while equation (i) was retained to model the earlier
period 1838 to 1878. New York data were extrapolated using equation (ii) to model
data beyond 1948.
In Switzerland (Fig. 6), streptomycin was introduced during 1947. The rate of
decline for TB after the introduction of this therapy was 0.042 (equation (ii) above)
but with extrapolation the rate is only 0.034 (equation (i) above). This corresponds to
a 24% increase in rate of decline through the use of antibiotics. Both the model data
and the real data reach a similar mortality rate of less than 1 per 100,000 by the end
of the real data (2005). At the time that streptomycin was introduced, mortality from
TB had already declined from 370 per 100,000 in 1867 to 77 in 1946. This is a decline
of 71%. The logistic model predicts a rate of 0.58, while the real data rate is 0.28.
Overall, in Switzerland, the introduction of streptomycin only served to slightly improve
the rate of mortality decline.
In England and Wales (Fig. 7), streptomycin was available in 1946. At this time,
the rate of decline with this therapy was 0.055 (equation (iii) above). The rate of
decline modelled by the logistic ﬁt (extrapolation) is 0.020 (equation (ii) above). This
is an increase of 175% in the rate of mortality decline. Thus, antibiotics did substan-
tially improve the rate of decline. Interestingly, the modelled data and the logistic
data do not reach the same levels by 2006 (when the real data end). The modelled
data reached 21 per 100,000 living while the real data declined to 0.70. This difference
suggests that there was a decline already occurring but that the factors responsible were
not sufﬁcient to fully control the disease. However, when streptomycin was introduced
the mortality rate had already declined by 90%. The rate decreased from 381 per
100,000 in 1838 to 40 in 1946.
As in Switzerland, streptomycin was available in 1947 in New York (Fig. 8). The
raw data were used (i.e. not Fig. 9) for the extrapolation because the logistic ﬁt chosen
was for 1922 to 1950. The logistic ﬁt of the data before this was not important for the
extrapolation (i.e. the section that was modiﬁed in Fig. 9). The rate of decline after this
time was 0.025 (equation (ii) above). The data did not signiﬁcantly alter with the intro-
duction of antibiotics, so there was no need to modify the logistic ﬁt. However, in
1950, the real and modelled data do differ slightly in terms of actual rate. The modelled
data predicted a rate of 38 per 100,000 in 1950, while the real data show a rate of 29.
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When streptomycin was introduced in 1947, the mortality rate had already declined
from 350 per 100,000 in 1878 (687 in 1803) to 42 in 1946. This is a decline of 88%.
This suggests that although streptomycin did not make a signiﬁcant impact on the
mortality rate during its introduction, it still was aiding the decline already occurring.
Discussion
The decline of tuberculosis
In Switzerland, England and Wales and the United States (New York), the decline
of mortality due to TB was continuous and steady throughout a period of more than
100 years. Medical intervention in the form of pharmacotherapies, including the
antibiotic streptomycin, was not responsible for the majority of the decline. Mortality
rates in Switzerland, England and Wales and the United States (New York) had
declined by 71%, 90% and 88%, respectively, before the introduction of streptomycin.
There was no speciﬁc event that was responsible for the majority of the decline; instead
it was a combination of many smaller changes in public health and disease control.
In Japan, mortality did not decline from an originally high level as was observed in
Switzerland, England and Wales and in the United States (New York). Instead, the
mortality increased from an originally low level, which would be associated with an
increasing level of industrialization at this time. During the 1930s, the Great Depres-
sion affected the living conditions of the Japanese, resulting in an increase in TB
mortality. This occurred just before World War II, which resulted in a continuation of
the same trend. It was not until after the war, when anti-TB drugs were introduced,
that TB in Japan was reduced to low mortality rates and controlled. Thus in Japan,
the decline in TB mortality was largely due to the implementation of drug therapy
for the disease. It could be postulated that the improvements in sanitation and living
conditions in post-war Japan may have lowered TB mortality rates even without the
introduction of pharmacotherapies, but it is impossible to separate the effects of these
measures from those of chemical intervention.
In Brazil, drug therapy was the major factor in the decline of TB mortality, though
the data show a slow decline approximately halving mortality rates between the end of
the 19th century and the time pharmacotherapies became available. Then when drug
therapy was introduced, mortality declined quickly within several years. The shape of
this mortality decline is not observed for Switzerland, England and Wales, or, New
York (United States) indicating that the major factors in the decline in TB mortality
were different from medical intervention in those countries. Sierra Leone shows the
data for a country where TB is becoming a major health problem. This trend would
probably have been observed for Switzerland, England and Wales and the United
States in earlier years not captured by the sources of information used.
Logistic ﬁtting
Logistic curves were ﬁtted to the mortality data for Switzerland, England and
Wales and the United States (New York) and all had R2 values above 0.97, indicating
a good ﬁt. This also indicates that the decline of TB mortality followed a logistic pattern.
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One single logistic equation was not satisfactory for a good ﬁt and consequently multiple
equations were needed. This indicated that multiple processes of decline in TB mortality
were operating during different years. In the years at the beginning of the study data,
it may be expected that implementation of public health reforms addressing hygiene,
nutrition, living conditions, etc. were the reason for the mortality decline. The mortality
decline associated with drug treatment was in some cases substantially faster than for
conservative methods and public health, but both had clear effects on the decline in
mortality rates. Extrapolation of the models to exclude the inﬂuence of antibiotics
showed that the mortality decline would have continued into the 21st century, even
without the introduction of pharmacotherapies. However, the mortality rates declined
quicker and reached lower values with antibiotic therapy.
Limitations of the study
One limitation of this study is the reliance on historical records. However, it includes
data from multiple countries over a number of years, all of which show the same trend
over time. These data also include years when TB notiﬁcation was compulsory and the
records can be considered reasonably accurate during these time periods.
One other limitation of this study is the change in cause of death nomenclature
through time. The disease has been recorded under many names including ‘tuberculosis’,
‘phthisis’ and ‘consumption’. Non-pulmonary TB has been known by multiple names
including ‘scrofula’ and ‘King’s Evil’. However, the nomenclature was deﬁned by the
ICD codes for causes of death in 1900, which was used by all Western as well as some
Eastern countries (including Japan). Thus this limitation is only a concern before this
year while much of the decline in TB mortality occurred during the early years of the
20th century.
Another problem with this study is the difﬁculty in differentiating the factors respon-
sible for the mortality decline. Each factor cannot be distinctly assessed for its role in
the mortality decline because the data provide only an overview of the effects of all
factors operating at that time.
Conservative measures and public health interventions can help to control TB
It is shown here that pharmacological interventions were not responsible for the
majority of the decline in TB in Switzerland, England and Wales and the United States
(New York). Instead, conservative and public health measures were effective in reduc-
ing the mortality from TB. This is even despite the obvious problems with compliance
and efﬁciency of the introduction of various public health measures. Hygiene/sanitation
and availability of proper health care were not uniformly distributed in the 19th and
early 20th centuries. This is shown by data from Drolet & Lowell (1952), describing
the differences in mortality rates for different areas of New York between 1900 and
1950. This is also true for many other cities in this time period. Clearly, however, even
partly ineffective implementation of conservative measures and public health can help
to control TB and this can be used in situations where TB is currently at high levels.
Conservative methods and public health will also be effective at controlling drug-resistant
TB, as pharmacotherapeutics are not the focus of treatment.
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However, phamacotherpeutics can be used to aid the control of TB as they can help
break transmission of the disease. Overall, as suggested by McKeown (1976), a reduc-
tion in prevalence will result in a lower level of exposure and transmission, which, in
the case of airborne infections, is the most important part of controlling the disease.
The only concern with using drug therapies as a major part of a disease control pro-
gramme is the development of drug resistance. This may be exacerbated by patient
non-compliance. Unlike public health measures and conservative methods, drug therapy
needs to be fully and efﬁciently implemented to be successful in controlling infections.
The World Health Organization initiated a ‘Stop TB Strategy’ in the 1990s when
HIV began to appear, resulting in an increase in the global burden of TB. A large
part of this strategy is the Directly Observed Treatment Short-Course (DOTS) regime.
This involves ﬁve separate elements including additional funding allocation, improved
detection of cases, standardized treatment where patients are assisted in ﬁnishing their
anti-TB drug programmes, development and maintenance of a reliable system for pro-
viding anti-TB drugs and an improvement in the recording system for cases (World
Health Organization, 2013). These elements, while important, do not address the patient’s
current environment such as poor living conditions and nutrition. Consequently, many
of these patients may receive a full course of anti-TB therapy, but may not be cured or
may relapse. With the addition of conservative measures as well as public health inter-
ventions, many cases of TB may be curable and many others preventable. The results
from this combination of treatments are shown by the data from Japan and Brazil.
There is a rapid reduction in TB mortality due mostly to pharmacological interventions,
accompanied by conservative measures and public health interventions.
Another problem with the DOTS strategy is the lack of active searching for cases.
In all countries (except Brazil) described here, an Act or Law was introduced that
required the recording and treatment of all TB cases. Switzerland introduced this in
1928, England and Wales in 1913, New York in 1897 and Japan in 1931. This type of
health policy would be helpful to implement in developing countries where TB cases
often go unnoticed until signs and symptoms have developed signiﬁcantly. While
DOTS does include assistance to patients for completing drug programmes through
visits from nursing staff, the focus is solely on the treatment rather than the living
standards of the patient. In New York, starting from 1939, nurses were required to visit
the homes of diagnosed TB patients and addressed the patient’s living conditions and
social status to aid recovery (Drolet & Lowell, 1952). Switzerland, England and Wales,
New York and Japan all introduced a Housing Law or Public Health Act aimed at
improving living conditions of all individuals. In 1901, New York outlined a speciﬁc
set of criteria that every building needed to meet in order to be satisfactory as a living
space. These included adequate lighting, ventilation, water supply, sanitary facilities
and a ﬁre escape (Drolet & Lowell, 1952). In particular, the requirement of ventilation
helped to prevent transmission of TB by dust particles in poorly ventilated areas. In
addition to these housing laws, factory laws were also introduced in all countries studied
here. These laws were aimed at improving the working conditions of those involved in
industry. These changes were very successful in reducing mortality; Japan in particular
saw a decrease in the mortality rate from TB in factory workers after the Factory Law
in 1926 allowed them to commute from home (Johnston, 1995). The situation in
Switzerland was different in that workers for common industries (e.g. cotton) had their
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work facilities installed in their own homes (Steinberg, 1996). Child labour was used in
Switzerland, but there was a restriction on the number of hours that a child could work
and schooling was still compulsory.
In England and Wales and New York, segregation of individuals with TB began
from the early 1900s, which helped prevent the spread of the disease in addition to im-
proving ventilation of living spaces (Drolet & Lowell, 1952; Fairchild & Oppenheimer,
1998). Speciﬁc institutions were constructed, called sanatoria, for TB patients and
treated patients using conservative measures such as improving nutrition through a
high-quality diet, allowing the patient to rest and providing a well-ventilated and sanitary
environment to reduce exposure to the pathogen (Roberts & Buikstra, 2003; Warren,
2006).
Gross domestic product (GDP) can give an indication of the level of economic
success and standard of living in a country. GDP per capita was very similar in Switzer-
land, England and Wales and the United States for 1900–1950. In Switzerland, GDP
per capita increased from 3833 to 4314 and ﬁnally to 9064 (all units: 1990 International
Geary-Khamis dollars) over the years 1900, 1920 and 1950 (Maddison, 2003). Com-
parative values for the UK are 4492, 4548 and 6939 dollars for 1900, 1920 and 1950,
respectively. For the US, the values are 4091, 5552 and 9561 dollars. When these values
are compared with Japan and Brazil, there is a large difference. In Japan, GDP per
capita for 1900, 1920 and 1949 was 1180, 1696 and 1800 dollars, well below the levels
of Switzerland, England and Wales and the United States. In Brazil, the values are 678,
963 and 1672 dollars. Economic success plays an important role in disease prevention
because it provides the necessary resources to improve infrastructure and the com-
munity. These values show that Switzerland, England and Wales and the United States
had higher economic success compared with Japan and Brazil, which is reﬂected in a
slower decline of TB mortality in the latter.
Public education was also very successful in reducing the overall burden of the
disease because TB patients were able to help control the disease by educating others
(Drolet & Lowell, 1952). Implementation of public health policies was widespread
throughout all countries described here and were all aimed at improving living con-
ditions of the entire population. These polices have been proven to be very effective
in aiding the decline of TB by providing a higher standard of living and hence an
improvement in the general level of health, allowing individuals to better combat infec-
tious pathogens. If these types of policies can be implemented in developing countries,
the DOTS strategy can be more effective and the risk of relapse can be reduced.
Conclusion
The decline in TB mortality during the 19th and 20th centuries in Switzerland,
England and Wales and the United States was largely due to a combination of con-
servative measures (rest, good nutrition, ventilation, etc.) and public health interven-
tions (addressing hygiene, nutrition, reducing exposure to infections and education
about TB). The introduction of anti-TB drug therapy played a small role in the mortality
decline in these countries. In Switzerland, 80% of the decline in TB mortality had
occurred before the introduction of streptomycin. In England and Wales and New
York, the declines were 90% and 88% complete, respectively, before anti-TB therapies.
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Antibiotics were effective in combination with conservative measures and public health
interventions in Brazil and Japan, suggesting that different strategies can reduce mortality
from TB, depending upon the local situation. Pharmacotherapies can be useful to reduce
mortality due to TB, but must be implemented efﬁciently in order to prevent resistance.
With regard to drug-resistant forms of TB it should be recommended to use the time-
honoured and proven methods of increasing general immunity and implementing con-
servative measures as well as public health interventions in addition to the expensive
and short-lived chemical therapies aimed at killing germs that have already entered the
bodies of patients. These conservative measures and public health interventions have
been proven to be effective, even when not implemented at full efﬁciency. Improving the
economies and public health policies of TB-infested countries is a life-saving imperative.
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